Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase II Study of VEGF-Trap in Recurrent or Metastatic Gynecologic Soft-Tissue Sarcomas

NCT00390234 is registered in ClinicalTrials.gov with National Cancer Institute (NCI) as lead sponsor.

NCT NCT00390234
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00390234 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase II Study of VEGF-Trap in Recurrent or Metastatic Gynecologic Soft-Tissue Sarcomas
Lead sponsor
National Cancer Institute (NCI)
Phase
Phase 2
Overall status
Completed
Start date
September 30, 2006
Completion date
August 31, 2013
Enrollment
63 (actual)
Sites
16

Conditions

As the registry lists them; a condition with its own page is linked.

fallopian tube cancer, female reproductive cancer, ovarian carcinosarcoma, ovarian sarcoma, recurrent ovarian epithelial cancer, recurrent uterine sarcoma, stage iii ovarian epithelial cancer, stage iii uterine sarcoma, stage iv ovarian epithelial cancer, stage iv uterine sarcoma, uterine carcinosarcoma, uterine leiomyosarcoma